Dermatology Advisor

Acne Risk in Atopic Dermatitis Is Doubled at 6-Months With JAK Inhibitors

Among patients with AD, receipt of JAK inhibitors was associated with an increased risk for acne compared with Th2 cytokine inhibitors.
Targeted Oncology

PIM-1 Inhibition Offers a Novel Approach in Myelofibrosis

Early-phase clinical trials involving PIM-1 kinase inhibitors look promising. In the evolving landscape of myelofibrosis (MF) ...
ascopubs.org

Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D In a RET-fusion ...
Association of Optometrists (AOP)

ROCK and role: the place of Rho-kinase inhibitors in glaucoma care

Moorfields Eye Hospital consultant ophthalmic surgeon, Sana Hamid, provided a summary of ROCK inhibitors at 100% Optical ...
Targeted Oncology

Early-Stage PIM-1 Kinase Inhibitors Explored in Myelofibrosis

Findings from a phase 1/2 trial (NCT04176) presented at the 2025 American Society of Hematology Annual Meeting and Exposition ...
The American Journal of Managed Care

Zanubrutinib Leads Other BTK Inhibitors Across B-Cell Lymphomas in Meta-Analysis

A two-step approach pooled indication-specific response rates, then generated naïve odds ratios via random-effects models, reflecting limited head-to-head evidence across BTK inhibitors. Across ...